| VIEW FROM THE TOP
INNOVATION: THE SHORTEST PATH TO EXCELLENCE ALEJANDRO PAOLINI Director General of Siemens Healthineers for Mexico, Central America and Caribbean
138
Q: What concrete actions is Siemens Healthineers taking
A: Today, healthcare systems worldwide are struggling
to improve access in Mexico?
to succeed financially and provide high-quality care
A: Our main goal is to develop solutions that allow increased
while facing scarce resources and restricted government
healthcare access with top of the line technology. We are
budgets. As a result, we decided to restructure our
working in line with local and international associations and
portfolio, expanding into new enterprise and digital
chambers to improve healthcare access in Mexico. For example,
health offerings, along with new business models that
we closely collaborate with COFEPRIS, which is imperative to
maximize opportunities and minimize risk to healthcare
ensure that the entire regulatory and control processes are
providers. We are reorienting our products to make them
carried out as efficiently as possible so the population can have
even more attractive to the health sector, especially for
faster access to the latest innovations in healthcare.
emerging markets. The objective is to satisfy the needs of our customers in Mexico by offering the highest
More than 70 percent of the world´s population dies from noncommunicable diseases, such as heart diseases, diabetes and cancer
technology and the best services. Q: How does Siemens Healthineers work with the public sector to make prevention the main focus of the industry? A: Healthcare systems worldwide are adopting prevention models to improve their population’s health and reduce costs along the entire healthcare chain. Technology is an important ally when facing this challenge. Siemens Healthineers can play a key role in this change of trend,
Q: One of the main proposals of Siemens Healthineers
since our portfolio is focused on prevention, early
is innovation. What have been the main advances in this
detection and monitoring.
regard in Mexico? A: Mexico is one of the key countries for Siemens
More than 70 percent of the world´s population dies
Healthineers. We are the only healthcare company in the
from noncommunicable diseases, such as heart disease,
market that has a broad and comprehensive portfolio
diabetes and cancer. If diagnosed early, they can be
focused on solutions and services for imaging and
treated and monitored, increasing patients’ survival rates
laboratory diagnostics. We do not have a production
and reducing costs for the healthcare chain. This is the
plant in Mexico and the innovation technologies are
value of technology for healthcare.
basically developed in Germany and the US, but that does not prevent us from introducing and implementing new
Q: “Patients will be treated as consumers.” What impact
technological developments in this country. When we think
does this statement has on the activities of Siemens
about innovation, we think about solutions that provide
Healthineers?
clinical, operational and financial excellence. For instance,
A: This paradigm shift is happening at a macro level and
in Mexico we launched a new laboratory technology called
aims to empower the patient, who are more informed and
Atellica Solution. This is a revolutionary platform that
want to take an active role in the medical decision-making
addresses laboratory challenges using immunoassays and
process. They are also deciding how they want to receive
clinical chemistry analyzers that transform care delivery.
and seek healthcare services. Here in Mexico for instance, out-of-pocket expenses are really high compared to other
Q: The reduction of federal budgets is a constant of the
countries, which is why patients assume they participate
Mexican health industry. How has Siemens Healthineers
in a more direct way. At Siemens Healthineers, patient
adapted to this trend?
experience is one of the company’s main pillars.
